Neurocrine Biosciences Inc SEC filings NBIX
Neurocrine Biosciences Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 8, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 31, 2026 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 POS | Filing | May 21, 2025 | — |
| S-8 | Employee stock plan registration | May 21, 2025 | — |
| S-8 | Employee stock plan registration | Aug 1, 2024 | — |
| S-8 | Employee stock plan registration | Aug 1, 2023 | — |
| S-8 | Employee stock plan registration | Aug 4, 2022 | — |
| S-8 POS | Filing | Aug 3, 2020 | — |
| S-8 | Employee stock plan registration | Aug 3, 2020 | — |
| S-8 | Employee stock plan registration | Nov 5, 2019 | — |
| S-8 | Employee stock plan registration | Aug 22, 2018 | — |
| S-8 | Employee stock plan registration | Feb 14, 2018 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- NBIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 914475
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.